Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 29, 2026
TickeronGET DAILY SIGNALS
Olin Corporation (OLN) Shares Q3 2026 Results Amid Commodity Pressures

Olin Corporation (OLN) Shares Q3 2026 Results Amid Commodity Pressures

Key Takeaways

  • Olin reported third quarter 2026 sales of $1.75 billion and net income of $14.4 million, or $0.13 per diluted share, down from $42.8 million in the prior-year quarter.
  • Results fell short of consensus: adjusted EPS of roughly $0.13–$0.14 came in below estimates near $0.15–$0.16, and revenue missed the $1.83–$1.84 billion consensus.
  • Adjusted EBITDA was $191.4 million, which management said was consistent with its expectations.
  • Segment results were mixed, with Chlor Alkali Products and Vinyls sales declining year over year while Epoxy and Winchester both grew.
  • Olin guided fourth quarter 2026 adjusted EBITDA to a range of $80 million to $100 million, citing seasonality and year-end customer destocking.
  • The company now expects its proposed merger with Huntsman to close in the first quarter of 2027.

Why These Earnings Matter

Olin Corporation operates as a major player in chemicals and ammunition through its Chlor Alkali Products and Vinyls, Epoxy, and Winchester segments. This quarter stands out because the company continues to navigate weak commodity chemical pricing, subsidized Asian exports, and higher feedstock costs that have compressed margins. The results also arrive as Olin moves forward with its proposed merger with Huntsman, which adds layers of integration and financing considerations for investors. With the stock trading well below its 52-week high and down sharply over the past year, the report offered a useful checkpoint on whether the value-first strategy can support earnings stability.

The Quarter in Detail

For the third quarter ended September 30, 2026, Olin posted sales of $1.75 billion, a modest increase from $1.71 billion a year earlier. Net income attributable to Olin Corporation reached $14.4 million, or $0.13 per diluted share, compared with $42.8 million in the same period last year. On a GAAP basis, these figures landed below analyst expectations of roughly $0.15–$0.16 per share, and revenue of $1.75 billion fell short of consensus estimates near $1.83–$1.84 billion.

Adjusted EBITDA came in at $191.4 million, which management viewed as aligned with its internal planning. Segment performance showed contrasts: Chlor Alkali Products and Vinyls sales dropped to $850.8 million from $924.0 million, while Epoxy sales climbed to $412.2 million from $349.6 million and Winchester sales rose to $484.7 million from $439.6 million. Acquisition-related costs tied to the Huntsman deal totaled $13.7 million in the quarter.

Looking ahead, Olin expects fourth quarter 2026 adjusted EBITDA in the $80 million to $100 million range, reflecting typical seasonality, year-end destocking by customers, higher feedstock costs, and planned maintenance turnarounds. The company also updated its timeline for the Huntsman transaction, now anticipating a close in the first quarter of 2027 subject to standard conditions.

Investor Reaction and Market Context

Heading into the release, expectations had softened and the stock had already declined roughly 20% since the start of the year while broader markets moved higher. The miss on both revenue and earnings lines highlighted ongoing challenges in chemical pricing and margins, even though adjusted EBITDA met management’s own targets. Shares have moved from a 52-week high near $30 down to the mid-teens, underscoring the pressure the business has faced. Investors continue to weigh the potential longer-term benefits of the Huntsman combination against near-term costs and uncertainties.

What to Watch Going Forward

The immediate focus is the fourth-quarter guidance, which signals a step down in adjusted EBITDA. Management pointed to seasonality, customer destocking, feedstock cost increases, Asian export pressures, and maintenance schedules as key drivers. I’m watching closely to see whether chemical prices stabilize and if volumes can help offset any further pricing weakness.

The Huntsman merger remains another important element, with the updated close window in the first quarter of 2027. Progress on regulatory approvals, integration planning, and financing will likely influence sentiment. In addition, the Beyond250 cost-savings program and the value-first approach stay central to margin improvement. Olin ended the quarter with net debt near $2.8 billion and a net debt to adjusted EBITDA ratio of about 5.2 times, so cash generation and cost control will stay relevant.

Using AI Tools in My Research Process

I also checked this using Tickeron’s AI Screener to compare Olin against other names in the sector and review technical setups. These tools help surface patterns and fundamentals efficiently when reviewing earnings reports like this one.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: OLN

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


OLN in -7.15% downward trend, declining for three consecutive days on November 20, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where OLN declined for three days, in 239 of 321 cases, the price declined further within the following month. The odds of a continued downward trend are 74%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OLN as a result. In 55 of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 74%.

The Moving Average Convergence Divergence Histogram (MACD) for OLN turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 34 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 71%.

OLN moved below its 50-day moving average on November 18, 2026 date and that indicates a change from an upward trend to a downward trend.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for OLN's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The 10-day moving average for OLN crossed bullishly above the 50-day moving average on November 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 60%.

Following a +13.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where OLN advanced for three days, in 180 of 273 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

OLN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 105 of 192 cases where OLN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 41 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.153) is normal, around the industry mean (1.147). P/E Ratio (-10.006) is within average values for comparable stocks, (3.243). Projected Growth (PEG Ratio) (1.050) is also within normal values, averaging (3.769). Dividend Yield (0.046) settles around the average of (0.195) among similar stocks. P/S Ratio (0.289) is also within normal values, averaging (0.578).

The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. OLN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OLN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

Notable companies

The most notable companies in this group are Dow (NYSE:DOW).

Industry description

The major diversified chemicals industry includes companies that produce a wide range of chemicals and industrial gases. The products are often used as raw materials in the manufacturing of various types of goods, including plastics, paints, carpets, and fixtures to name a few. Major companies making diversified chemicals include DuPont de Nemours Inc., Celanese Corporation, Celanese Corporation and Westlake Chemical Corporation.

Market Cap

The average market capitalization across the Chemicals: Major Diversified Industry is 2.83B. The market cap for tickers in the group ranges from 80.4K to 67.31B. SHECF holds the highest valuation in this group at 67.31B. The lowest valued company is DEVV at 80.4K.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Major Diversified Industry was -16%. For the same Industry, the average monthly price growth was -15%, and the average quarterly price growth was -31%. GURE experienced the highest price growth at -2%, while TROX experienced the biggest fall at -44%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Major Diversified Industry was 43%. For the same stocks of the Industry, the average monthly volume growth was 5% and the average quarterly volume growth was 2%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 52
Price Growth Rating: 62
SMR Rating: 84
Profit Risk Rating: 89
Seasonality Score: 5 (-100 ... +100)
AI Screener 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company which engages in manufacturing and distributing the chemicals products

Industry ChemicalsMajorDiversified

Industry
Industrial Specialties
Address
190 Carondelet Plaza
Phone
+1 314 480-1400
Employees
7849
Web
https://www.olin.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.